xCELLigence RTCA HT-BioTek BioSpa8, Scientists Choice Awards 2024 Winner
xCELLigence RTCA HT-BioTek BioSpa8 – Screening Model
Integration of the Agilent xCELLigence Real Time Cell Analyzer (RTCA) HT instrument with the Agilent BioTek BioSpa 8 automated incubator expands the screening throughput of your xCELLigence RTCA HT instrument to up to eight 384-well E-Plates. Label-free high-throughput xCELLigence Real-Time Cell Analysis is ideal for screening viral mediated cytopathic effects (CPE), neutralizing antibodies, antibody-dependent cytotoxicity (ADCC), and compound mediated cytotoxicity.
xCELLigence Real-Time Cell Analysis uses impedance-based biosensors to continuously obtain non-invasive, label-free data on cell health, behavior, and function with high accuracy, sensitivity, and reproducibility. Integrating the BioSpa 8 Automated Incubator with the xCELLigence RTCA HT model enables live-cell analysis of up to 3,072 wells to meet high throughput sample screening needs.
xCELLigence Real-Time Cell Analysis uses impedance-based biosensors to continuously obtain non-invasive, label-free data on cell health, behavior, and function with high accuracy, sensitivity, and reproducibility. Integrating the BioSpa 8 Automated Incubator with the xCELLigence RTCA HT model enables live-cell analysis of up to 3,072 wells to meet high throughput sample screening needs.
Download the product brochure using the DOWNLOADS button above, or request more information about the xCELLigence RTCA HT-BioTek BioSpa8 – Screening Model